KMDA Kamada Ltd.
Healthcare$7.95+1.53%ClosedMarket Cap: $458.6M
As of 2026-05-26
Valuation
P/E (TTM)
24.16
PEG
0.60
P/B
1.78
P/S
2.49
EV/EBITDA
11.25
DCF Value
$19.48
FCF Yield
3.7%
Div Yield
3.2%
Margins & Returns
Gross Margin
41.2%
Operating Margin
14.0%
Net Margin
11.2%
ROE
7.7%
ROA
5.3%
ROIC
7.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $45.2M | 42.3% | $7.0M | $4.1M | $— | $0.19 |
| Q4 null | $44.7M | 38.0% | $3.6M | $3.6M | $— | — |
| FY null | $180.5M | 42.3% | $26.2M | $20.2M | $— | $0.20 |
| Q3 null | $47.0M | 42.0% | $7.8M | $5.3M | $— | — |
| Q2 null | $44.8M | 42.3% | $7.1M | $7.4M | $— | — |
| Q1 null | $44.0M | 47.1% | $7.8M | $4.0M | $— | $0.20 |
| Q4 null | $39.0M | 43.7% | $5.1M | $3.8M | $— | — |
| FY null | $161.0M | 43.5% | $20.1M | $14.5M | $— | — |
| Q3 null | $41.7M | 41.3% | $5.3M | $3.9M | $— | — |
| Q2 null | $42.5M | 44.6% | $5.6M | $4.4M | $— | — |
| Q1 null | $37.7M | 44.4% | $4.0M | $2.4M | $— | — |
| Q4 2023 | $36.4M | 39.6% | $2.8M | $5.1M | $0.09 | — |